Opus Genetics
IRD
49 hedge funds and large institutions have $12.6M invested in Opus Genetics in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 11 closing their positions.
199% more call options, than puts
Call options by funds: $239K | Put options by funds: $80K
0.32% more ownership
Funds ownership: 17.55% → 17.87% (+0.32%)
0% more funds holding
Funds holding: 49 → 49 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
21% less capital invested
Capital invested by funds: $16M → $12.6M (-$3.38M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$225K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$167K |
| 3 |
BlackRock
New York
|
+$152K |
| 4 |
LPL Financial
San Diego,
California
|
+$132K |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$130K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$432K |
| 2 |
TAM
Tucker Asset Management
Littleton,
Colorado
|
-$126K |
| 3 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$118K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$111K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$109K |
IRD Hedge Fund Activity: Q3 2023 in Review
49 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2023, worth a combined $12.6M — down 21% from $16M a quarter earlier.
Fund positioning in IRD was balanced in Q3 2023: 11 funds opened new positions, 11 closed out, 11 added to existing stakes and 12 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $225K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $432K sold.
- 49 institutional investors held Opus Genetics (IRD) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $12.6M of Opus Genetics stock for Q3 2023, down 21% quarter-over-quarter.
- 11 funds opened new Opus Genetics positions in Q3 2023 and 11 closed out, a net change of 0 holders.
- The largest Opus Genetics buyer in Q3 2023 was Susquehanna International Group, an estimated $225K added.
- The largest Opus Genetics seller in Q3 2023 was Renaissance Technologies, an estimated $432K sold.
Based on aggregated 13F filings for Q3 2023.